DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483,722 | +15.1% | 32,751 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $420,129 | +153.4% | 32,504 | +92.3% | 0.00% | – |
| Q1 2023 | $165,807 | -18.4% | 16,902 | -11.8% | 0.00% | – |
| Q4 2022 | $203,160 | -8.5% | 19,162 | -9.8% | 0.00% | -100.0% |
| Q3 2022 | $222,000 | +26.9% | 21,237 | +53.9% | 0.00% | – |
| Q2 2022 | $175,000 | +49.6% | 13,803 | +27.9% | 0.00% | – |
| Q1 2022 | $117,000 | -26.4% | 10,791 | -4.8% | 0.00% | – |
| Q4 2021 | $159,000 | -83.4% | 11,340 | -77.3% | 0.00% | -100.0% |
| Q3 2021 | $958,000 | +194.8% | 50,044 | +51.3% | 0.00% | +100.0% |
| Q2 2021 | $325,000 | +59.3% | 33,080 | +59.0% | 0.00% | – |
| Q1 2021 | $204,000 | +973.7% | 20,811 | +389.7% | 0.00% | – |
| Q4 2020 | $19,000 | 0.0% | 4,250 | -5.7% | 0.00% | – |
| Q3 2020 | $19,000 | -68.9% | 4,505 | -36.0% | 0.00% | – |
| Q2 2020 | $61,000 | +165.2% | 7,041 | +7.6% | 0.00% | – |
| Q1 2020 | $23,000 | – | 6,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |